Frietsch, Jochen J. https://orcid.org/0000-0002-1476-8059
Miethke, Jenny
Linke, Paul
Crodel, Carl C.
Schnetzke, Ulf
Scholl, Sebastian
Hochhaus, Andreas
Hilgendorf, Inken https://orcid.org/0000-0003-2038-9730
Article History
Received: 15 March 2022
Revised: 25 April 2022
Accepted: 27 April 2022
First Online: 10 May 2022
Competing interests
: IH received honoraria from Novartis and ABBVIE and has obtained travel, accommodation or expenses from medac GmbH, Janssen-Ciliag, Jazz Pharmaceuticals and Celgene. AH received research support by Novartis, BMS, Pfizer, and Incyte. The other authors do not declare any conflicts of interest.
: Based on Thuringian law and our clinical Ethics Committee, reports providing routinely collected data do not need approval by Ethics Committee. Written informed consent was obtained from our patients for publication in this report. A copy of written consent is available for review.